Top Biotech Fund Continues Huge Insider Buying: Seattle Genetics, TransDigm, JC Penney and More

Photo of Lee Jackson
By Lee Jackson Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Top Biotech Fund Continues Huge Insider Buying: Seattle Genetics, TransDigm, JC Penney and More

© Thinkstock

The roller-coaster market ride continued this past week, but that didn’t stop insiders from continuing to buy shares. With first-quarter earnings reporting now just three short weeks away, the window for many insiders to make transactions may be starting to close. While the buying wasn’t as prolific as what we saw when the market was getting pummeled in January and February, it remains consistent.

We cover insider buying every week at 24/7 Wall St., and we like to remind our readers that while insider buying is usually a very positive sign, it is not in and of itself a reason to run out and buy a stock. Sometimes insiders and 10% owners have stock purchase plans set up at intervals to add to their holdings. That aside, it still remains a positive indicator.

Here are some of the companies that reported notable insider buying this past week.

Seattle Genetics Inc. (NASDAQ: SGEN) had one of the biggest biopharmaceutical funds buying more shares of the stock again this past week. The Baker Brothers acquired 349,323 shares of the company at prices between $32.36 and $33.69 apiece. The total for that buy was a very impressive $11 million. This biotechnology company develops and commercializes antibody-based therapies for the treatment of cancer. The stock closed Friday at $33.36.
[recirclink id=320026]
TransDigm Group Inc. (NYSE: TDG) had a director at the company make a very significant purchase this past week. That director bought a total of 41,655 shares at prices that ranged from $219.68 to $221.79. The total for the trade came in at a rich $9 million. The company designs, produces and supplies aircraft components in the United States. The stock closed on Friday at $221.17.

Kennedy-Wilson Holdings Inc. (NYSE: KW) saw some of the people at the top of the company buying shares last week. The chief executive officer, an executive vice president and the general counsel at the company purchased a total of 96,938 shares at between $20.26 and $20.92 apiece. The total came to an even $2 million. Kennedy-Wilson operates as a real estate investment and services company in the United States, the United Kingdom, Ireland, Jersey, Spain and Japan. The stock ended the week at $21.97.

Taser International Inc. (NASDAQ: TASR) had a director accumulating shares of the company recently. That director purchased a block of 100,000 shares at a share price of $19.85. That cost the director just under the $2 million. The company develops, manufactures and sells conducted electrical weapons worldwide. Its share price was $19.53 as trading ended on Friday.

American Assets Trust Inc. (NYSE: AAT) saw the man at the top buying shares this week. CEO Ernest Rady scooped up 39,448 shares of the company at prices that fell between $37.66 and $37.69 per share. The total for the buy came in right at $1.5 million. This U.S. real estate investment trust (REIT) owns, operates, acquires and develops retail, office, multifamily and mixed-use properties, primarily in southern and northern California and in Hawaii. The stock closed Friday at $38.28.

These companies also reported insider buying this week: American Homes 4 Rent (NYSE: AMH), Carbo Ceramics Inc. (NYSE: CRR), Huntington Bancshares Inc. (NASDAQ: HBAN), Intrepid Potash Inc. (NYSE: IPI), JC Penney Co. Inc. (NYSE: JCP) and TPG Specialty Lending Inc. (NYSE: TSLX).

As mentioned, while the volumes are down from the massive buying we saw during the big sell-off, they are still quite respectable. It is possible though that things will indeed slow down as earnings season comes into the picture.

Photo of Lee Jackson
About the Author Lee Jackson →

Lee Jackson has covered Wall Street analysts' equity and debt research and equity strategy daily for 24/7 Wall St. since 2012. His broad and diverse career, which included a stint as the creative services director at the NBC affiliate in Austin, Texas, gives him unique insight into the financial industry and world.

Lee Jackson's journey in the financial industry spans over 30 years, with nearly two decades as an institutional equity salesperson at Bear Stearns, Lehman Brothers, and Morgan Stanley. His career was marked by his presence on the sell side during pivotal Wall Street events, from the dot.com rise and bubble to the Long Term Capital Management debacle, 9/11, and the Great Recession of 2008. This is a testament to his resilience and adaptability in the face of market volatility.

Lee Jackson’s practical financial industry experience, acquired from a career at some of the biggest banks and brokerage firms, is complemented by a lifetime of writing on various platforms. This unique combination allows him to shed light on the intricacies and workings of Wall Street in a way that only someone with deep insider experience and knowledge can. Moreover, his extensive network across Wall Street continues to provide direct access for him and 24/7 Wall St., a privilege few firms enjoy.

Since 2012, Jackson’s work for 24/7 Wall St. has been featured in Barron’s, Yahoo Finance, MarketWatch, Business Insider, TradingView, Real Money, The Street, Seeking Alpha, Benzinga, and other media outlets. He attended the prestigious Cranbrook Schools in Bloomfield Hills, Michigan, and has a degree in broadcasting from the Specs Howard School of Media Arts.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618